Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Venclexta

Tag: Venclexta

Study Reinforces the Potential of Pivekimab Sunirine as a Novel Addition...

ADC Review | Editorial Team
Initial safety and efficacy findings from an open-label, dose-escalation and expansion cohorts of the Phase 1b/2 study of pivekimab sunirine (IMGN632), a CD123 (Interleukin-3 alpha...

Polatuzumab Vedotin in the Treatment of Patients with Previously Untreated Diffuse...

ADC Review | Editorial Team
Diffuse large B-cell lymphoma (DLBCL), the most common type of an aggressive form of non-Hodgkin lymphoma (NHL) in the United States and worldwide, is...

ImmunoGen Initiates Pivotal Trial Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

ADC Review | Editorial Team
Biotech company ImmunoGen, leveraging the targeting ability of antibodies to deliver cytotoxic drugs directly to cancer cells by developing the next generation of antibody-drug...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X